MSH2 and endometrial cancer: Therefore, in our current study, we stably introduced four LS-associated missense mutations into the MSH2-null human endometrial cancer cell line Hec59 to determine their effects on in vivo cellular functions such as DNA repair and checkpoint response (Table 1).